High‑throughput NGS case
A Robert‑Debré Hospital case study shows an Agilent NGS setup processing more than 5,000 samples per year, claiming improved accuracy and throughput from automation. The example was shared as a model for scaling NGS workflows in clinical settings. ( )
Next-generation sequencing is a way to read millions of DNA fragments at once, and one Paris hospital says automation let that work scale past 5,000 samples a year. (cancer.gov, agilent.com) At Robert-Debré Hospital, part of AP-HP Nord–Université Paris Cité, the molecular genetics laboratory said it now processes more than 5,000 samples annually, including about 3,000 constitutional samples and 2,500 somatic samples. (agilent.com, aphp.fr) The lab said it built a single workflow for constitutional, somatic, and prenatal testing, using two Bravo next-generation sequencing workstations, one Magnis preparation system, one 4200 TapeStation, and two 2100 Bioanalyzer systems from Agilent. (agilent.com) In sequencing, “library preparation” is the step where DNA is cut, tagged, and readied for the machine, and “quality control” is the checkpoint that screens out weak samples before a run starts. The National Cancer Institute says next-generation sequencing can identify changes across whole genomes, exomes, multigene panels, and RNA, while the Centers for Disease Control and Prevention says labs use quality systems to keep those results reliable. (cancer.gov, cdc.gov) Agilent’s case study says automation reduced hands-on work, simplified training for new users, and helped the lab handle urgent cases with more consistent processing. The company attributed the gains to standardizing library preparation, target enrichment, and quality control inside one setup. (agilent.com, cellandgene.com) Robert-Debré is a pediatric hospital, and its genetics department handles diagnosis, prenatal testing, counseling, and research for children and families with genetic disorders. AP-HP says the hospital’s medical biology activity includes genetics, fetopathology, cytogenetics, neurodevelopment, brain disorders, and childhood cancers. (robertdebre.aphp.fr, aphp.fr) Clinical sequencing labs have pushed toward automation because the process has many repetitive liquid-handling steps, and errors at the sample-prep stage can waste a full sequencing run. Guidance from the Centers for Disease Control and Prevention and the American College of Medical Genetics and Genomics both emphasizes validation, ongoing quality monitoring, and standardized procedures in clinical next-generation sequencing. (cdc.gov, nature.com) The Robert-Debré example comes from an Agilent customer case study, so the throughput and accuracy claims are the vendor’s account of the site’s experience, not an independent comparative trial. What it shows clearly is that one hospital lab is using automation as a template for running high-volume sequencing across several clinical sample types. (agilent.com, cellandgene.com)
